Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03834922Completed

Providing Standardized Consented PROMs (Patient Reported Outcome Measures) for Improving Pain Treatment

Role: collaborator

NCT03624712Recruiting

Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms

Role: collaborator

NCT05925790Recruiting

Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR Levels

Role: collaborator

NCT02544360Not ApplicableUnknown

A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools

Role: collaborator

NCT00159107Phase 4Completed

Integrative Therapy in Alcoholism

Role: collaborator

All 5 trials loaded